David L. Hava
2016
In 2016, David L. Hava earned a total compensation of $611.3K as Chief Scientific Officer at Pulmatrix, a 76% decrease compared to previous year.
Compensation breakdown
| Bonus | $44,246 |
|---|---|
| Option Awards | $267,581 |
| Salary | $293,824 |
| Other | $5,684 |
| Total | $611,335 |
Hava received $293.8K in salary, accounting for 48% of the total pay in 2016.
Hava also received $44.2K in bonus, $267.6K in option awards and $5.7K in other compensation.
Rankings
In 2016, David L. Hava's compensation ranked 10,463rd out of 14,075 executives tracked by ExecPay. In other words, Hava earned more than 25.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,463 out of 14,075 | 26th |
Division Manufacturing | 4,040 out of 5,486 | 26th |
Major group Chemicals And Allied Products | 1,430 out of 1,900 | 25th |
Industry group Drugs | 1,145 out of 1,543 | 26th |
Industry Pharmaceutical Preparations | 892 out of 1,173 | 24th |
Source: SEC filing on April 28, 2017.
Hava's colleagues
We found four more compensation records of executives who worked with David L. Hava at Pulmatrix in 2016.